Aperion Biologics Report issue

For profit Phase 1 Phase 2
Founded: San Antonio TX United States (2008)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2009
NCT00886353
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now